Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 1 | 1 | 32 |
| Other current assets | 0 | 0 | 178 | 168 | 0 |
| TOTAL | $78 | $103 | $209 | $230 | $143 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $78 | $103 | $209 | $230 | $143 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,587 | 5,480 | 5,236 | 5,058 | 5,139 |
| Accrued Expenses | 2,969 | 2,789 | 2,609 | 2,409 | 2,132 |
| TOTAL | $10,975 | $10,707 | $9,923 | $9,323 | $8,959 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 234 | 264 | 294 | 332 | 0 |
| TOTAL | $234 | $264 | $294 | $332 | $N/A |
| Total Liabilities | $11,209 | $10,971 | $10,217 | $9,655 | $8,959 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 119,594 | 102,774 | 97,894 | 94,908 | 90,397 |
| Common Shares | 117 | 98 | 98 | 90 | 90 |
| Retained earnings | -175,296 | -174,815 | -173,955 | -173,181 | -172,473 |
| Other shareholders' equity | 22 | 22 | 22 | 22 | 22 |
| TOTAL | $-11,132 | $-10,868 | $-10,008 | $-9,425 | $-8,817 |
| Total Liabilities And Equity | $78 | $103 | $209 | $230 | $142 |